6-month versus 12-month dual antiplatelet therapy after implantation of 2nd generation drug-eluting stents with Biolimus-eluting Versus Zotarolimus-eluting stent: Prospective, Randomized, Multicenter Trial

被引：1
|
作者：
Lee, Byoung Kwon [1 ]
Bum-Kee, Hong [1 ]
Yoon, Young Won [1 ]
Min, Pil-Ki [2 ]
Kwon, Hyuck Moon [2 ]
Kim, Byoung Keuk [3 ]
Hong, Myeong-Ki [3 ]
Jang, Yang Soo [3 ]
机构：
[1] Yonsei Univ, Gangnam Severance Hosp, Seoul 120749, South Korea
[2] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Div Cardiol, Cardiovasc Ctr, Seoul, South Korea
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2013年 / 62卷 / 18期
关键词：
D O I：
10.1016/j.jacc.2013.08.735
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：B3 / B4
页数：2
相关论文
共 50 条
  • [1] Outcomes of ≤6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation A meta-analysis and meta-regression
    Villablanca, Pedro A.
    Massera, Daniele
    Mathew, Verghese
    Bangalore, Sripal
    Christia, Panagiota
    Perez, Irving
    Wan, Ningxin
    Schulz-Schuepke, Stefanie
    Briceno, David F.
    Bortnick, Anna E.
    Garcia, Mario J.
    Lucariello, Richard
    Menegus, Mark
    Pyo, Robert
    Wiley, Jose
    Ramakrishna, Harish
    MEDICINE, 2016, 95 (52)
  • [2] Second-Generation Drug-Eluting Stent Implantation Followed by 6-Versus 12-Month Dual Antiplatelet Therapy The SECURITY Randomized Clinical Trial
    Colombo, Antonio
    Chieffo, Alaide
    Frasheri, Arian
    Garbo, Roberto
    Masotti-Centol, Monica
    Salvatella, Neus
    Dominguez, Juan Francisco Oteo
    Steffanon, Luigi
    Tarantini, Giuseppe
    Presbitero, Patrizia
    Menozzi, Alberto
    Pucci, Edoardo
    Mauri, Josepa
    Cesana, Bruno Mario
    Giustino, Gennaro
    Sardella, Gennaro
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (20) : 2086 - 2097
  • [3] Clopidogrel Versus Aspirin as an Antiplatelet Monotherapy After 12-Month Dual-Antiplatelet Therapy in the Era of Drug-Eluting Stents
    Park, Taek Kyu
    Song, Young Bin
    Ahn, Joonghyun
    Carriere, K. C.
    Hahn, Joo-Yong
    Yang, Jeong Hoon
    Choi, Seung-Hyuk
    Choi, Jin-Ho
    Lee, Sang Hoon
    Gwon, Hyeon-Cheol
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (01)
  • [4] The Safety of 6-Month versus 12-Month Dual Antiplatelet Therapy in Patients Treated with Zotarolimus-Eluting Stent: A Patient-Level Pooled Analysis of Five ENDEAVOR Randomized Trials
    Mehran, Roxana
    Kandzari, David E.
    Mauri, Laura
    Caixeta, Adriano
    Dangas, George
    Negoita, Manuela
    Leon, Martin B.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (8A): : 168I - 169I
  • [5] SIX MONTHS OCT OUTCOMES OF BIODEGRADABLE POLYMER BIOLIMUS-ELUTING STENTS VERSUS DURABLE POLYMER ZOTAROLIMUS-ELUTING STENTS IN PATIENTS WITH CAD: PROSPECTIVE, RANDOMIZED, MULTICENTER TRIAL
    Lee, Byoung Kwon
    Kwon, Hyuck Moon
    Yoon, Young Won
    Min, Pil-Ki
    Hong, Bum-Kee
    Hong, Myeong-Ki
    Jang, Yang Soo
    Kim, Byeong-Keuk
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1192 - E1192
  • [6] Short-Duration Versus Guideline-Recommended 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stents Implantation
    Stefanini, Giulio G.
    Siontis, Georgios
    Cao, Davide
    Heg, Dik
    Jueni, Peter
    Windecker, Stephan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B143 - B143
  • [7] A multicenter randomized comparison of drug-eluting balloon plus bare metal stent versus bare metal stent versus drug-eluting stent in bifurcation lesions: 6-month angiographic and 12-month clinical r
    Belkacemi, A.
    Agostoni, P.
    Doevendans, P. A.
    Dubois, C.
    Nathoe, H. M.
    Dens, J.
    Naber, C.
    Voskuil, M.
    Stella, P. R.
    EUROPEAN HEART JOURNAL, 2011, 32 : 1042 - 1042
  • [8] 6-Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin The Randomized, Multicenter ITALIC Trial
    Gilard, Martine
    Barragan, Paul
    Noryani, Arif A. L.
    Noor, Hussam A.
    Majwal, Talib
    Hovasse, Thomas
    Castellant, Philippe
    Schneeberger, Michel
    Maillard, Luc
    Bressolette, Erwan
    Wojcik, Jaroslaw
    Delarche, Nicolas
    Blanchard, Didier
    Jouve, Bernard
    Ormezzano, Olivier
    Paganelli, Franck
    Levy, Gilles
    Sainsous, Joel
    Carrie, Didier
    Furber, Alain
    Berland, Jacques
    Darremont, Oliver
    Le Breton, Herve
    Lyuycx-Bore, Anne
    Gommeaux, Antoine
    Cassat, Claude
    Kermarrec, Alain
    Cazaux, Pierre
    Druelles, Philippe
    Dauphin, Raphael
    Armengaud, Jean
    Dupouy, Patrick
    Champagnac, Didier
    Ohlmann, Patrick
    Endresen, Knut
    Benamer, Hakim
    Kiss, Robert Gabor
    Ungi, Imre
    Boschat, Jacques
    Morice, Marie-Claude
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (08) : 777 - 786
  • [9] 6-Month Versus 12-Month Dual-Antiplatelet Therapy Following Long Everolimus-Eluting Stent Implantation The IVUS-XPL Randomized Clinical Trial
    Hong, Sung-Jin
    Shin, Dong-Ho
    Kim, Jung-Sun
    Kim, Byeong-Keuk
    Ko, Young-Guk
    Choi, Donghoon
    Her, Ae-Young
    Kim, Yong Hoon
    Jang, Yangsoo
    Hong, Myeong-Ki
    JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (14) : 1438 - 1446
  • [10] A prospective, randomized, open-label trial of 6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction: Rationale and design of the "DAPT-STEMI trial"
    Kedhi, Elvin
    Fabris, Enrico
    van der Ent, Martin
    Kennedy, Mark W.
    Buszman, Pawel
    von Birgelen, Clemens
    Cook, Stephan
    Wedel, Hans
    Zijlstra, Felix
    AMERICAN HEART JOURNAL, 2017, 188 : 11 - 17
12345